Key result
Comprehensive CMD testing may improve symptoms and QoL by guiding targeted medical therapy.
Why the study?
Coronary microvascular disease causes myocardial ischemia in diverse clinical scenarios, but additional education and provider awareness are needed to improve patient-centered outcomes in ischemic heart disease.
Design
Review
Authors
Loading...
May support CMD testing to guide therapy in select patients; hypothesis-generating and requires RCTs before practice change.
Comprehensive invasive testing for coronary microvascular disease can guide targeted therapy and improve patient outcomes in various clinical scenarios.
Smilowitz et al. (2023) conducted a review in Coronary microvascular disease. Testing for coronary microvascular disease was evaluated. Comprehensive testing for coronary microvascular disease may improve symptoms and quality of life by establishing a diagnosis and guiding targeted medical therapy across various clinical scenarios.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: